MyoTRIM – A Promising New Treatment for Muscular Dystrophy – Hosted by CRD

In this discussion with Dr. Noah Weisleder, PhD, from the Weisleder Lab at Ohio State University College of Medicine, and Rich Horgan, founder and CEO of Cure Rare Disease, we’ll delve into the promising research being conducted by Dr. Weisleders’s lab to develop MyoTRIM – a non-viral, protein-based therapy. We’ll discuss findings from the early-stage research, applications for the treatment of various forms of muscular dystrophy, and more.